Synthesis and structure–activity relationship studies of MI-2 analogues as MALT1 inhibitors-Reference-Cited by-同舟云学术

Synthesis and structure–activity relationship studies of MI-2 analogues as MALT1 inhibitors

Published:2018-07 Issue:12 Volume:26 Page:3321-3344
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Wu Guolin,Wang Haixia,Zhou Wenhui,Zeng Bihua,Mo Wenhui,Zhu Kejie,Liu Rong^ORCID,Zhou Jia^ORCID,Chen Ceshi,Chen Haijun

Funder

Chinese Academy of Sciences

National Nature Science Foundation of China

Yunnan Applied Basic Research Key Projects

West Light Foundation of the Chinese Academy of Sciences

Youth Innovation Promotion Association

Scientific Research Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference56 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma;Project TN-HsLC;The non-Hodgkin's lymphoma classification project. Blood.,1997

3. Targeting pathological B cell receptor signalling in lymphoid malignancies;Young;Nat Rev Drug Discov.,2013

4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

5. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma;Rosenwald;J Exp Med,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cinchona-Alkaloid-Derived NNP Ligand for Iridium-Catalyzed Asymmetric Hydrogenation of β-Keto Ester;The Journal of Organic Chemistry;2024-01-24

2. Rational design of novel pyridine-based drugs candidates for lymphoma therapy;Journal of Molecular Structure;2022-12

3. Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases;Biochemical Pharmacology;2022-04

4. Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma;Journal of Medicinal Chemistry;2021-06-28

5. MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies;Medicinal Research Reviews;2021-03-25